Cargando…

Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis

INTRODUCTION: Loricrin is usually observed in abundance in keratinizing epithelium in response to mechanical stress, which may be associated with development and malignant transformations in conditions such as oral submucous fibrosis (OSMF). Therefore, understanding of various molecular mechanisms a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahapatra, Niva, Dash, Kailash C, Bhuyan, Lipsa, Panda, Abikshyeet, Behura, Shyam S, Mishra, Pallavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595509/
https://www.ncbi.nlm.nih.gov/pubmed/33149468
http://dx.doi.org/10.4103/jpbs.JPBS_79_20
_version_ 1783601891683336192
author Mahapatra, Niva
Dash, Kailash C
Bhuyan, Lipsa
Panda, Abikshyeet
Behura, Shyam S
Mishra, Pallavi
author_facet Mahapatra, Niva
Dash, Kailash C
Bhuyan, Lipsa
Panda, Abikshyeet
Behura, Shyam S
Mishra, Pallavi
author_sort Mahapatra, Niva
collection PubMed
description INTRODUCTION: Loricrin is usually observed in abundance in keratinizing epithelium in response to mechanical stress, which may be associated with development and malignant transformations in conditions such as oral submucous fibrosis (OSMF). Therefore, understanding of various molecular mechanisms associated with difference in gene expressions between OSMF and that of normal oral tissue is important. AIM: The aim of this study was to evaluate of the efficacy of loricrin as a diagnostic marker in patients with OSMF. MATERIALS AND METHODS: Fifty formalin-fixed paraffin-embedded tissue blocks were obtained from the archives of the department. The study sample was grouped into two groups of normal mucosa (group I; n = 20) and OSMF (group II; n = 30) specimens. The study tissues were immunohistochemically stained with loricrin antibody and were further graded on basis of staining intensity. RESULTS: Loricrin immunostaining was observed significantly more in OSMF cases and even in stratum granulosum in comparison to normal mucosa. CONCLUSION: Loricrin can act as an early indicator and a prognostic marker for detection of deleterious changes within epithelium in OSMF.
format Online
Article
Text
id pubmed-7595509
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-75955092020-11-03 Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis Mahapatra, Niva Dash, Kailash C Bhuyan, Lipsa Panda, Abikshyeet Behura, Shyam S Mishra, Pallavi J Pharm Bioallied Sci Original Article INTRODUCTION: Loricrin is usually observed in abundance in keratinizing epithelium in response to mechanical stress, which may be associated with development and malignant transformations in conditions such as oral submucous fibrosis (OSMF). Therefore, understanding of various molecular mechanisms associated with difference in gene expressions between OSMF and that of normal oral tissue is important. AIM: The aim of this study was to evaluate of the efficacy of loricrin as a diagnostic marker in patients with OSMF. MATERIALS AND METHODS: Fifty formalin-fixed paraffin-embedded tissue blocks were obtained from the archives of the department. The study sample was grouped into two groups of normal mucosa (group I; n = 20) and OSMF (group II; n = 30) specimens. The study tissues were immunohistochemically stained with loricrin antibody and were further graded on basis of staining intensity. RESULTS: Loricrin immunostaining was observed significantly more in OSMF cases and even in stratum granulosum in comparison to normal mucosa. CONCLUSION: Loricrin can act as an early indicator and a prognostic marker for detection of deleterious changes within epithelium in OSMF. Wolters Kluwer - Medknow 2020-08 2020-08-28 /pmc/articles/PMC7595509/ /pubmed/33149468 http://dx.doi.org/10.4103/jpbs.JPBS_79_20 Text en Copyright: © 2020 Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mahapatra, Niva
Dash, Kailash C
Bhuyan, Lipsa
Panda, Abikshyeet
Behura, Shyam S
Mishra, Pallavi
Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis
title Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis
title_full Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis
title_fullStr Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis
title_full_unstemmed Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis
title_short Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis
title_sort evaluation of the efficacy of loricrin as a diagnostic marker in patients with oral submucous fibrosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595509/
https://www.ncbi.nlm.nih.gov/pubmed/33149468
http://dx.doi.org/10.4103/jpbs.JPBS_79_20
work_keys_str_mv AT mahapatraniva evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis
AT dashkailashc evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis
AT bhuyanlipsa evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis
AT pandaabikshyeet evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis
AT behurashyams evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis
AT mishrapallavi evaluationoftheefficacyofloricrinasadiagnosticmarkerinpatientswithoralsubmucousfibrosis